Skip to main content
Caplight Logo









WuXi Diagnostics

WuXi Diagnostics

Private
ShanghaiHealthcare & Life Scienceshttps://www.wuxidiagnostics.com/

Last Round

Series B

Feb 23, 2021

Est. Valuation

$22.77M

Total Funding Raised

$154.55M

Company Overview

WuXi Diagnostics is a healthcare company that provides an integrated clinical diagnostic platform offering testing solutions from research to clinical practice, including screening, early diagnosis, clinical decision support, and prognosis management.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

clinical laboratory testingdiagnostic platformlab servicesdiagnostic supply chainclinical decision supportdiagnostic algorithmslab-as-a-servicemulti-omicshealthcare logisticsprecision medicinediagnostic reagentsmedical testingclinical diagnosticsbiotech supply chainlab management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

WuXi Diagnostics Comparables

Compare WuXi Diagnostics with similar companies based on industry and business-model similarity.

WuXi Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Guangzhou Huayin Health Technology Co., Ltd.
78%
Guangzhou Kingmed Diagnostics Group Co Ltd
76%
Dian Diagnostics Group
73%

WuXi Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 23, 2021
Series AOct 18, 2019
Joint VentureJan 25, 2018

Key People

Founding team and executive leadership

Rex Zhao

Chief Operating Officer

Executive Team

WuXi Diagnostics Investors

Notable investors and investment history

WuXi Diagnostics investors
InvestorRounds
Sunland FundSeries B
Agricultural Bank of China InternationalSeries B
Lake Bleu CapitalSeries A
CCB InternationalSeries B
CCBI Tech VentureSeries B
Shiyu CapitalSeries B
Yunfeng CapitalSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 7, 2026

    Monthly visitors grew 588% MoM, from 99 to 681.

WuXi Diagnostics Filings

Explore SEC and related filing metadata, where available.

WuXi Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about WuXi Diagnostics's valuation, stock price, and market status.

Is WuXi Diagnostics a public or private company?

WuXi Diagnostics is a private company.

What is the current stock price of WuXi Diagnostics?

WuXi Diagnostics is a private company with no public stock price. No recent secondary market data is available.

How much is WuXi Diagnostics worth (valuation)?

Valuation information for WuXi Diagnostics is not publicly available.

Can I buy WuXi Diagnostics stock?

WuXi Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was WuXi Diagnostics's last funding round?

WuXi Diagnostics's most recent funding round was Series B on February 23, 2021.

Who are the main investors in WuXi Diagnostics?

Key investors in WuXi Diagnostics include Yunfeng Capital.

Will WuXi Diagnostics IPO soon?

No public IPO plans have been announced for WuXi Diagnostics.

How can I track WuXi Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor WuXi Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Employee Range40
Year Founded2018
Last FundingFeb 23, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?